predictors of early mortality in patients with wild-type transthyretin amyloidosis
Published 2 months ago • 76 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:03
real-world management of patients with al amyloidosis
-
6:39
manifestations in attr amyloidosis
-
2:09
heart transplantation in attr amyloidosis
-
1:16
considering enrolment in clinical trials for patients with amyloidosis
-
22:25
blood biomarkers to detect alzheimer disease
-
8:37
what is amyloidosis? | symptoms, diagnosis, treatment | visual explanation
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
1:33
rnai therapeutics for attr amyloidosis
-
2:15
the role of pet/ct in assessing early treatment response in patients with ndmm
-
1:26
incidence and risk factors associated with vod/sos in younger vs older adults after sct
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:59
the importance of early diagnosis in al amyloidosis to improve outcomes for patients
-
2:58
the potential role of pet/ct imaging in the early diagnosis and monitoring of attr amyloidosis
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
1:59
the importance of raising awareness and early diagnosis in amyloidosis
-
2:34
the impact of ethnicity on biomarker-based staging in al amyloidosis
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:45
real-world data in guiding amyloidosis treatment
-
4:04
management of al amyloidosis: measurement modalities, transplantation & car-t
-
2:13
personalizing the timing of sct in patients with myelofibrosis
-
1:37
predictors of unsustained mrd negativity in transplant-eligible patients with multiple myeloma